New possibilities of pathogenetic therapy for allergic rhinitis

Медицинский совет

卷:0

L. I. Krivopalova¹  A. A. Krivopalov²  S. A. Rebrova² 

[1] Petersburg Metro Polyclinic, St. Petersburg;

[2] Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Healthcare of Russia, St. Petersburg;

关键词: allergic rhinitis;    rhinoconjunctivitis;    second-generation antihistamines;    bilastine;   

DOI  :  10.21518/2079-701X-2018-20-89-91

来源: DOAJ

【 摘 要 】

Allergic rhinitis is one of the most common human diseases that affect patients’ quality of of life. There has been a significant increase in incidence rates related to allergic rhinitis in the Russian Federation and the world. Second-generation antihistamines having high H1-receptor affinity constitute the main pharmacological group for the treatment of allergic rhinitis. The article presents an overview of Bilastin as a novel drug of the above group.

【 授权许可】

Unknown